ANGPTL4 Induces Aberrant Lymphatic-Like Remodeling in Proliferative Diabetic Retinopathy

Area of Science:

• Ophthalmology
• Diabetic Retinopathy Research
• Vascular Biology

Background:

• Proliferative diabetic retinopathy (PDR) poses a significant challenge due to poor response to anti-vascular endothelial growth factor (anti-VEGF) therapy in some patients.
• The need for alternative therapeutic strategies is evident, necessitating a deeper understanding of PDR pathophysiology beyond VEGF pathways.

Purpose of the Study:

• To investigate the role of Angiopoietin-like 4 (ANGPTL4) in PDR, particularly in cases unresponsive to anti-VEGF treatment.
• To elucidate the specific mechanisms by which ANGPTL4 contributes to PDR pathology.

Main Methods:

• Analysis of ANGPTL4 levels in the vitreous humor of PDR patients with varying responses to anti-VEGF therapy.
• Experimental induction of diabetic conditions in mice to study the effects of ANGPTL4 on retinal structures.

Main Results:

• ANGPTL4 was found to be elevated in the vitreous humor of PDR patients exhibiting poor responses to anti-VEGF therapy.
• The C-terminal fragment of ANGPTL4 was demonstrated to induce retinal lymphatic-like remodeling in a mouse model of diabetes.

Conclusions:

• ANGPTL4 represents a potential therapeutic target for PDR, distinct from VEGF.
• Findings highlight the intricate relationship between immune activation, neovascularization, and lymphatic-like remodeling in PDR pathogenesis.